These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 12051751)

  • 41. A multifunctional teal-fluorescent Rosa26 reporter mouse line for Cre- and Flp-mediated recombination.
    Imayoshi I; Hirano K; Sakamoto M; Miyoshi G; Imura T; Kitano S; Miyachi H; Kageyama R
    Neurosci Res; 2012 May; 73(1):85-91. PubMed ID: 22343123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of the fate of Sry-expressing cells using an in vivo Cre/loxP system.
    Ito M; Yokouchi K; Yoshida K; Kano K; Naito K; Miyazaki J; Tojo H
    Dev Growth Differ; 2006 Jan; 48(1):41-7. PubMed ID: 16466392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Highly efficient transgene-independent recombination directed by a maternally derived SOX2CRE transgene.
    Vincent SD; Robertson EJ
    Genesis; 2003 Oct; 37(2):54-6. PubMed ID: 14595840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Podocyte cell-specific expression of doxycycline inducible Cre recombinase in mice.
    Juhila J; Roozendaal R; Lassila M; Verbeek SJ; Holthofer H
    J Am Soc Nephrol; 2006 Mar; 17(3):648-54. PubMed ID: 16467448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prokaryotic expression of DNA recombinase FLP and its purification with enzymatic activity].
    Gai Y; Wang WQ; Lu H; Jiang XN
    Sheng Wu Gong Cheng Xue Bao; 2007 Jul; 23(4):724-9. PubMed ID: 17822052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Engineering cell-permeant FLP recombinase for tightly controlled inducible and reversible overexpression in embryonic stem cells.
    Patsch C; Peitz M; Otte DM; Kesseler D; Jungverdorben J; Wunderlich FT; Brüstle O; Zimmer A; Edenhofer F
    Stem Cells; 2010 May; 28(5):894-902. PubMed ID: 20333748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases.
    Gavériaux-Ruff C; Kieffer BL
    Pharmacol Ther; 2007 Mar; 113(3):619-34. PubMed ID: 17289150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conditional expression of anti-apoptotic protein p35 by Cre-mediated DNA recombination in cardiomyocytes from loxP-p35-transgenic mice.
    Araki T; Shibata M; Takano R; Hisahara S; Imamura Si; Fukuuchi Y; Saruta T; Okano H; Miura M
    Cell Death Differ; 2000 May; 7(5):485-92. PubMed ID: 10800082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Cre-loxP solution for defining the brain renin-angiotensin system. Focus on "Targeted viral delivery of Cre recombinase induces conditional gene deletion in cardiovascular circuits of the mouse brain".
    Phillips MI
    Physiol Genomics; 2004 Jun; 18(1):1-3. PubMed ID: 15205485
    [No Abstract]   [Full Text] [Related]  

  • 50. Dual renin gene targeting by Cre-mediated interchromosomal recombination.
    Matsusaka T; Kon V; Takaya J; Katori H; Chen X; Miyazaki J; Homma T; Fogo A; Ichikawa I
    Genomics; 2000 Mar; 64(2):127-31. PubMed ID: 10729219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction of Cre recombinase toxicity in proliferating Drosophila cells by estrogen-dependent activity regulation.
    Heidmann D; Lehner CF
    Dev Genes Evol; 2001 Sep; 211(8-9):458-65. PubMed ID: 11685583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rhodopsin-iCre transgenic mouse line for Cre-mediated rod-specific gene targeting.
    Li S; Chen D; Sauvé Y; McCandless J; Chen YJ; Chen CK
    Genesis; 2005 Feb; 41(2):73-80. PubMed ID: 15682388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 'GM-gene-deletor': fused loxP-FRT recognition sequences dramatically improve the efficiency of FLP or CRE recombinase on transgene excision from pollen and seed of tobacco plants.
    Luo K; Duan H; Zhao D; Zheng X; Deng W; Chen Y; Stewart CN; McAvoy R; Jiang X; Wu Y; He A; Pei Y; Li Y
    Plant Biotechnol J; 2007 Mar; 5(2):263-274. PubMed ID: 17309681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conditional activation of RhoA suppresses the epithelial to mesenchymal transition at the primitive streak during mouse gastrulation.
    Fuse T; Kanai Y; Kanai-Azuma M; Suzuki M; Nakamura K; Mori H; Hayashi Y; Mishina M
    Biochem Biophys Res Commun; 2004 Jun; 318(3):665-72. PubMed ID: 15144889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inner hair cell Cre-expressing transgenic mouse.
    Li M; Tian Y; Fritzsch B; Gao J; Wu X; Zuo J
    Genesis; 2004 Jul; 39(3):173-7. PubMed ID: 15282743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuron-specific recombination by Cre recombinase inserted into the murine tau locus.
    Muramatsu K; Hashimoto Y; Uemura T; Kunii M; Harada R; Sato T; Morikawa A; Harada A
    Biochem Biophys Res Commun; 2008 Jun; 370(3):419-23. PubMed ID: 18381201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene conversion in transgenic maize plants expressing FLP/FRT and Cre/loxP site-specific recombination systems.
    Djukanovic V; Orczyk W; Gao H; Sun X; Garrett N; Zhen S; Gordon-Kamm W; Barton J; Lyznik LA
    Plant Biotechnol J; 2006 May; 4(3):345-57. PubMed ID: 17147640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inducible gene targeting in mice using the Cre/lox system.
    Sauer B
    Methods; 1998 Apr; 14(4):381-92. PubMed ID: 9608509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cre expression in primary spermatocytes: a tool for genetic engineering of the germ line.
    Vidal F; Sage J; Cuzin F; Rassoulzadegan M
    Mol Reprod Dev; 1998 Nov; 51(3):274-80. PubMed ID: 9771647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temporal regulation of Cre-recombinase activity in Scl-positive neurons of the central nervous system.
    Bradley CK; Takano EA; Göthert JR; Göttgens B; Green AR; Begley CG; van Eekelen JA
    Genesis; 2007 Mar; 45(3):145-51. PubMed ID: 17330263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.